News



Jan 2019

New lab positions available (PhD, Postdoc, TA)

Dec 2018

Clonal hematopoiesis contribute to ischemic heart failure - published in JAMA Cardiology

link

Dec 2018

New TA position available

Dec 2018

New Postdoc position available

Nov 2018

Public Report about Rieger Lab

link

Sept 2018

Excellence Cluster Cardio-Pulmonary-Institute funded!

link

Aug 2018

Michael invited speaker at ISEH 2018 in Los Angeles

June 2018

New PostDoc position available

Feb 2018

MiRNA-193b in AML - great story published in JCO

link

Dec 2017

Bartosch successfully defended his thesis - congrats Dr. Wojcik

Dec 2017

Bartosch and Fabian published Perspective Article in ONCOTARGET

link

Dec 2017

Michael appointed Frankfurt Congress Ambassador

link

Nov 2017

Collaborative Research Centre SFB834 renewed for 4 more years!

Sept 2017

Michael re-elected Board member of German Stem Cell Network GSCN

Aug 2017

Great Success for ISEH 2017 in Frankfurt

June 2017

Review on Single Cell Technologies published in FEBS Lett - congrats to Ilaria and Malak

link

May 2017

The group contributed to an intriguing story in "Cell"

link

March 2017

Patrizia receives K.H.Bauer-Prize from the DGCH - congrats!

link

March 2017

NEW LAB POSITIONS available

link

Feb 2017

DKTK Joint Funding Project accepted

Dec 2016

Fabian and Bartosch publish in LEUKEMIA - well done!

link



Basic Mechanisms in Stem Cell Biology

Stem cells raise enormous hope and expectations for regenerative medicine. Since decades hematopoietic stem cell transplantation has become routine treatment for many blood disorders and cancer and is a prime example for successfully applied regenerative medicine. However, many fundamental questions must be addressed for improved therapeutic options in the future.

We focus our research on basic mechanisms that control stem cell fate decisions (self-renewal vs. differentiation, lineage choice, quiescence vs. proliferation). These fate decisions need to be strictly balanced for normal tissue regeneration and for emergency situations, and are dysregulated in diseases (e.g. cancer). We utilize various organ stem cell systems (hematopoietic cells, mammary gland, colon) from mice and humans to unravel molecular and functional clues how these decisions are integrated in normal stem cell biology and how malignant stem cells can be targeted for innovative disease treatment.

Our Mission

We need a detailed knowledge about normal stem cell behavior to create innovative therapies for dysregulated stem-cell driven diseases.

Back to Top

portrait Michael Rieger

Prof. Dr. Michael Rieger

Curriculum Vitae

Supported by